![]()
Key Takeaways
- Many compounds fail due to breakdown or poor absorption, not chemical flaws.
- Enhancement improves performance without altering the original molecular structure.
- Nanoparticles, liposomes, and depot systems extend circulation and improve targeting.
- Enhancement reduces development risk by building on validated compounds and known safety data.
- Delivery-route optimization helps a single compound succeed across multiple therapeutic formats.




